By InvitationNot Applicable

The Effectiveness of Interventions Targeting Self-Perception of Aging in Older Adults with Subjective Cognitive Decline

China64 participantsStarted 2024-11-01

Plain-language summary

Subjective cognitive decline (SCD) represents the initial clinical manifestation in the disease spectrum of Alzheimer's Disease (AD). It represents an essential stage for early prevention and treatment of cognitive impairment, making the SCD population an optimal target for prior intervention. This study aims to assess the feasibility and efficacy of an 8-week intervention targeting self-perception of aging in community-dwelling older adults with SCD.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * aged ≥60 years; * residing in the community for 6 months at least; * experiencing a consistent decline in self-reported cognitive abilities; * having standard cognitive test performance in the normal range; * willing to participate in this study. Exclusion Criteria: * having diagnosis of any neurological diseases including Parkinson's disease, brain tumor, cerebral infarction, encephalitis, epilepsy, etc.; * having diagnosis of mental illness such as depression, anxiety, bipolar disorder, and schizophrenia; * with history of substance abuse or addiction; * with severe visual or hearing impairment.

What they're measuring

Subjective Cognitive Decline

Timeframe: Baseline (pre-intervention)，8 weeks (post-intervention)，and 16 weeks (follow-up)

Trial details

NCT IDNCT06622889

SponsorZheng Li

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-30

View on ClinicalTrials.gov More Subjective Cognitive Decline (SCD) trials